Elvis
@ElvisHysa
Followers
443
Following
3K
Media
67
Statuses
363
Rheumatologist, MD, PhDc. Special interest for PMR/GCA, capillaroscopy/systemic sclerosis and rheumatic irAEs. Passionate about travelling and music 🗺🎶
Genova, Liguria
Joined May 2015
New Immunology for the Rheumatologist case-based review: This state-of-the-art review summarizes our current understanding of immune checkpoint inhibitor associated inflammatory arthritis and promising avenues for future research Arthritis & Rheumatology https://t.co/vCQm5SYnTH
0
15
35
In this study, we stratified #PMR patients by frailty, showing multimorbidity is the main driver of GC-related AEs. Early DMARDs may help avoid reaching the ~1.2g cumulative prednisone dosage associated with AEs in our cohort. https://t.co/BJUEMWKooT Thankful to all colleagues💙
1
1
3
🔬 Monocytes drive lung fibrosis in systemic sclerosis: New research characterizes circulating monocytes and cultured macrophages from SSc patients with progressive vs. non-progressive interstitial lung disease, revealing distinct profibrotic signatures in those with worsening
0
6
12
The #ACR is about science, yes — but also about reconnecting with friends and people who make this journey special. @ElvisHysa @DrGiovanniAdami @victoriakonzett
1
2
11
Enriching experience at the Global Speed Mentoring Session during #ACR25! Inspiring conversations with senior mentors from around the world: grateful for their openness, insights, and encouragement for the next generation in rheumatology. 🌍💬 #rheumtwitter #EMEUNET #ACR2025
1
0
6
Thank you to the Global Research Exchange Program 2025 in @NorthwesternU @PanlarLeague @gladel_latam and @ACRheum It was an exciting experience to have the opportunity to share my research with colleagues from around the world and to learn from you. #Education #Lupus #ACR2025
🎉 Congratulations to all the brilliant minds participating in the Global Research Exchange Program this week! 🌍✨ Hosted by Eric Ruderman, MD, at @NorthwesternU, this prestigious gathering brings together early career #rheum researchers from @eular_org, @APLAR_org, &
0
1
2
Exciting sessions at the #ACR2025 Global Exchange Research Programme: a space for learning, sharing, and connecting! Our presentations encouraged stimulating discussions and new ideas for future projects, receiving valuable feedback from colleagues. #EMEUNET #ACR25 #rheumtwitter
1
2
25
🚀 Meet Elvis Hysa, one of our enthusiastic #EMEUNET #ACR2025 Ambassadors! During #ACR25, he’ll be reporting on the ACR-EULAR Research Exchange Program, sharing scientific highlights and personal impressions. 👉 Join him on X: @ElvisHysa
0
1
8
🔥NARRATIVE Review - Wiley Online Library A matter arising: When should inflammatory and autoimmune rheumatic diseases be considered ‘early’? 🔗 https://t.co/Y1vP2WXt5t ✍️🏽ElvisHysa EmanueleGotelli CarmenPizzorni SabrinaPaolino AlbertoSulli VanessaSmith RosannaCampitiello
0
3
6
Secukinumab in PMR is a positive! The phase 3 REPLENISH meets primary and all secondary endpoints, in contrast to the negative secukinumab in GCA study, designed in parallel. Enormous hope for the very large number of people living with PMR. @RheumNow
https://t.co/OqJSvXLwp1
novartis.com
1
11
47
📝 The 2025 EULAR update on lupus nephritis management is out! ✅ 4 overarching principles ✅ 13 recommendations for clinical practice 🔗 https://t.co/0RqSaONY81
3
55
136
🚀Join us on the EULAR - EMEUNET webinar: "GCA and Takayasu: Updates on Diagnosis and Management", and learn the latest advancements in large-vessel vasculitis. 🖥️Tuesday, 25 November 2025, 12:00 - 13:00 CET Register here: https://t.co/pvskRNK9Iz
#Rheumatology
0
6
13
Intertwined manifestations of spondyloarthritis & polymyalgia rheumatica can challenge diagnostic expertise. This study described clinical, imaging, & treatment char. of a cohort of patients with SpA spectrum disorders initially presenting as PMR A&R https://t.co/SrUeVbJOVD
0
10
21
In this review, we explore how #macrophage plasticity shapes inflammation, fibrosis and clinical outcomes in inflammatory and autoimmune rheumatic diseases (#RA, #SLE, #SSc, #PMR, #GCA) and how treatments modulate these phenotypes. Grateful to the team for making this happen💙
New content online: Dynamic macrophage phenotypes in autoimmune and inflammatory rheumatic diseases https://t.co/LuuA5TCyJh
4
2
12
Our study shows nailfold #capillaroscopy strongly correlates with skin disease activity in juvenile #dermatomyositis! 82% of children showed "scleroderma-like" pattern. Anti-TIF1γ patients had more severe capillary loss. @ClinRheumatol #rheumtwitter
https://t.co/hfLfb9jEfH
link.springer.com
Clinical Rheumatology - Juvenile dermatomyositis (jDM) is a systemic autoimmune disease mainly affecting the skeletal muscle and skin. The aim of our study was to investigate the possible...
0
0
2
Our paper is out! We show that GM-CSF drives early bone damage in RA—even before arthritis begins—and that JAK inhibitors can suppress this progression. A long journey, but worth it! https://t.co/GATt7JbPRY
link.springer.com
Arthritis Research & Therapy - Osteitis on magnetic resonance imaging (MRI) and bone microstructure changes (BMC) on high-resolution peripheral quantitative computed tomography (CT) are the...
3
13
38